Prospects for chemoprevention of cancer

Journal of Internal Medicine

Volumn 251, Issue 4, 2002, Pages 286-300

  Tamimi, R M ^a   Lagiou, P ^a,b   Adami, H O ^a,c   Trichopoulos, D ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Anti inflammatories; Antioestrogens; Antioxidants; Cancer; Chemoprevention; Diet derived agents

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIANDROGEN; ANTIESTROGEN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; CURCUMIN; CYCLOOXYGENASE 2; EPIGALLOCATECHIN GALLATE; FINASTERIDE; FLAVONOID; FOLIC ACID; INDOMETACIN; ISOFLAVONE; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; PIROXICAM; RALOXIFENE; RETINOID; RETINOL DERIVATIVE; RETINOL PALMITATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SELENIUM; TAMOXIFEN; TUROSTERIDE; UNINDEXED DRUG; VITAMIN D;

BREAST CARCINOMA; CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIET; DRUG MECHANISM; ESOPHAGUS CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; LARGE INTESTINE CANCER; LIVER CARCINOMA; LUNG CARCINOMA; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SKIN CARCINOMA; STOMACH CARCINOMA; TEA;

ANDROGEN ANTAGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CHEMOPREVENTION; DIET; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; MALE; MOLECULAR BIOLOGY; NEOPLASMS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036271834     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00969.x     Document Type: Review

References (167)

1. Recent cancer trends in the United States
2. The role of epidemiology in cancer prevention
3. A genetic model for colorectal tumorigenesis
4. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus
5. Genetic progression model for head and neck cancer: Implications for field cancerization
6. Clonal expansion of p53 mutant cells is associated with brain tumour progression
7. Partial allelotype of carcinoma in situ of the human bladder
8. Molecular detection of primary bladder cancer by microsatellite analysis
9. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers
10. Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents
11. Hormonal carcinogenesis
12. Selective estrogen receptor modulators: Structure, function, and clinical use
13. Mechanistic considerations in chemopreventive drug development
14. Colorectal cancer risk, chronic illnesses, operations, and medications: Case-control results from the Melbourne Colorectal Cancer Study
15. Aspirin and the risk of colorectal cancer in women
16. Colon cancer prevention by NSAIDs. What is the mechanism of action?
17. Cyclooxygenase-2 and carcino-genesis
18. Vitamin A and lung cancer
19. Vegetables, fruit, and cancer. I. Epidemiology
20. Epidemiologic evidence for beta-carotene and cancer prevention
21. Nutrition and lung cancer
22. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A
23. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer
24. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial
25. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease
26. Epidemiologic evidence regarding vitamin C and cancer
27. Vitamin E as an antioxidant in vitro and in vivo
28. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer
29. Effect of dietary vitamin E on dimethylhydrazine-induced colonic tumors in mice
30. Dietary antioxidants and the risk of lung cancer
31. Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites
32. Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: Pooled data from five cohorts
33. Case-control study of diet and invasive cervical cancer
34. Diet and the risk of invasive cervical cancer among white women in the United States
35. Diet and the risk of in situ cervical cancer among white women in the United States
36. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
37. Biochemical function of selenium and its relation to vitamin E
38. Mechanisms of selenium inhibition of tumorigenesis
39. Oxygen-centered free radicals as mediators of inflammation
40. Dietary and biochemical aspects of vitamin E
41. Selenium and cancer
42. Selenium in forage crops and cancer mortality in forage crops and cancer mortality in US counties
43. The importance of selenium to human health
44. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial
45. Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin
46. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver
47. Tyrosine protein kinase activity in the DMBA-induced rat mammary tumor: Inhibition by quercetin
48. Genistein, a specific inhibitor of tyrosine-specific protein kinases
49. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens
50. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
51. Antioxidant properties of polyphenols extracted from green and black teas
52. Enhancement of antioxidant and phase II enzyme by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible role in cancer chemoprevention
53. The effects of phenethyl isothiocynate, N-acetylcysteine and green tea on tobacco smoke induced lung tumors in strain A/J mice
54. Effects of green tea catechins in a rat multi-organ carcinogenesis model
55. The effect of Chinese tea on the occurrence of esophageal tumor induced by N-nitrosomethylbenzylamine in rats
56. The effect of Chinese tea on the occurrence of esophageal tumors induced by N-nitrosomethylbenzylamine in rats
57. Anti-promotion effect of green tea extracts on pancreatic cancer in golden hamsters induced by N-nitroso-bis(2-oxopropyl) amine
58. Inhibitory effects of beta-carotene, palm carotene, and green tea polyphenols on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl) amine in Syrian golden hamsters
59. Effect of six edible plants on the development of AFB1-induced gamma-glutamyltrans-peptidase positive hepatocyte foci in rats
60. Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea
61. Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[alpha]anthracene
62. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats
63. Cancer chemoprevention by polyphenols in green tea and artichoke
64. Tea and cancer: A review of the epidemiologic evidence
65. Green tea and leukoplakia
66. Oestrogenic potency of genistin and daidzin in mice
67. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein
68. Legumes and soybeans: Overview of their nutritional profiles and health effects
69. Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells
70. Curcumin modifies Apc (min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc (min) mice
71. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate
72. Inhibitory effects of curcumin on tumorigenesis in mice
73. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice
74. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
75. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: Comparison with the protective effect of beta-carotene
76. Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin
77. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]an-thracene-induced mammary cancer in rats
78. Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene
79. 13-cis-retinoic acid in the treatment of oral leukoplakia
80. Retinoids as preventive ad therapeutic anticancer agents (Part 1)
81. Fenretinide (4-HPR) in chemoprevention of oral leukoplakia
82. Retinoids as cancer-preventive agents
83. Micronutrients (vitamins and minerals) as cancer-preventive agents
84. Is vitamin D deficiency a risk factor for prostate cancer?
85. Vitamin D and prostate cancer: A prediagnostic study with stored sera
86. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: A hypothesis
87. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency
88. Folate intake and carcinogenesis of the colon and rectum
89. Folate, methionine, and alcohol intake and risk of colorectal adenoma
90. Estimates of the worldwide incidence of eighteen major cancers in 1985
91. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden
92. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis
93. Tamoxifen and contralateral breast cancer
94. The prevention of breast cancer
95. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
96. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
97. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study
98. A brief review of the current breast cancer prevention trials and proposals for future trials
99. Chemoprevention of breast cancer with tamoxifen
100. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial
101. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
102. Is Helicobacter pylori really the cause of gastric cancer?
103. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population
104. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays
105. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma
106. Vegetable and fruit consumption and cancer risk
107. Diet and hepatocellular carcinoma
108. Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers
109. Curcumin-containing diets inhibits diethylnitrosamine-induced murine hepato-carcinogenesis
110. Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population
111. Diet and risk of esophageal cancer by histologic type in a low-risk population
112. Nutrition intervention trials in Linxian, China: Multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia
113. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: Results from the General Population Trial in Linxian, China
114. Patterns of absolute risk of lung cancer mortality in former smokers
115. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of base-line characteristics and study compliance
116. Malignant melanoma
117. Cancer statistics, 1997
118. An overview of skin cancers. Incidence and causation
119. Molecular mechanisms of ultraviolet radiation carcinogenesis
120. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
121. DNA damage in UV-irradiated human skin in vivo: Automated direct measurement by image analysis (thymine dimers) compared with indirect measurement (unscheduled DNA synthesis) and protection by 5-methoxypsoralen
122. Tea and cancer
123. Inhibitory effect of tannins on direct-acting mutagens
124. Green tea and skin anticarcinogenic effects
125. Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green tea
126. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: A randomized, double-blind, controlled trial
127. Ultraviolet light and free radicals: An immunologic theory of epidermal carcinogenesis
128. Biology of cutaneous squamous cell carcinoma
129. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
130. Nutrition and cancer: A summary of the evidence
131. Chemoprevention of rat prostate carcinogenesis by use of finasteride or casodex
132. Effect of early treatment of prostate cancer with the 5-alpha-reductase inhibitor turo-steride in Dunning R3327 prostatic carcinoma in rats
133. Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia
134. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
135. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
136. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
137. Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines
138. Genetic alterations during colorectal-tumor development
139. Nutritional factors in colorectal cancer risk: A case control study in Majorca
140. Selected micronutrient intake and the risk of colorectal cancer
141. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas
142. Multivitamin use, folate, and colon cancer in women in the Nurse's' Health Study
143. Role of bile acids in colorectal carcinogenesis
144. Role of calcium in colon cancer prevention: Experimental and clinical studies
145. Dietary and supplemental calcium and the recurrence of colorectal adenomas
146. Calcium, vitamin D and colorectal cancer: A review of the epidemiologic evidence
147. Calcium supplements for the prevention of colorectal adenomas
148. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
149. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels
150. Review article: Cyclooxygenase - A target for colon cancer prevention
151. Colon cancer: A role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs
152. Low-dose aspirin and incidence of colorectal tumors in a randomized trial
153. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3
154. Oestrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women
155. Postmenopausal hormone use and risk for colorectal cancer and adenoma
156. Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States
157. Hormone replacement therapy and risk of colon and rectal cancer
158. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas
159. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas